Outcomes of Gastrostomy Placement with and without Concomitant Tracheostomy among Ventilator Dependent Children
jpedsurg.org shows its articles on its own site.
Read the article on jpedsurg.org ↗Article · Mar 2021 · 1 min read
In brief
In brief
Retrospective study of 1,100 ventilator-dependent children under 2 years demonstrates that simultaneous gastrostomy and tracheostomy placement does not increase postoperative complications compared to gastrostomy alone. Combined procedures may safely reduce anesthetic exposure in this high-risk population.
Written by the GCMD Library team from the article.
Abstract
Introduction
Simultaneous gastrostomy tube (GT) and tracheostomy placement in young children offers potential benefit in limiting anesthetic exposure, but it is unknown whether combining these procedures introduces additional morbidity. This study compared outcomes after combined GT and tracheostomy placement versus GT placement alone among similar ventilator-dependent patients.
Methods
Ventilator-dependent children <2-years-old who underwent GT placement alone (MV-GT), simultaneous GT and tracheostomy placement (GT+T), and GT placement alone with a pre-existing tracheostomy (T-GT) were identified using 2012–2018 NSQIP-Pediatric Participant User Files. Multiple logistic regression models were used to compare outcomes while adjusting for other group differences.
Results
Among 1100 children, 351 underwent MV-GT, 494 GT+T, and 255 T-GT. Major complications occurred in 23.6%, 17.0%, and 14.5% of the respective groups (p = 0.01). Major complications with GT+T were similar to T-GT (adjusted odds ratio [aOR]=1.19, 95%CI:0.78–1.83, p = 0.4) and lower than MV-GT (aOR=0.67, 95%CI:0.47–0.95, p = 0.02). Severe complications including mortality, cardiac arrest, and stroke were similar between the three groups (p = 0.8).
Conclusions
Children <2-years-old undergoing GT+T did not experience higher post-operative complications compared to children undergoing T-GT or MV-GT. Utilizing GT+T to limit anesthetic exposure may be reasonable within this high-risk population.
Type of Study
Treatment Study
Level of Evidence
Level III